References for Follow-up after prostate cancer treatment: what happens next?

Follow-up: An overview

National Institute for Health and Clinical Excellence, Prostate Cancer: Diagnosis and Treatment (Full guidance); London: February 2008

Heidenreich A, Bastian PJ, Bellmunt J et al. Guidelines on Prostate Cancer. European Association of Urology. 2012.

What symptoms should I look out for?

Heidenreich A, Bastian PJ, Bellmunt J et al. Guidelines on Prostate Cancer. European Association of Urology. 2013.

Side effects

Heidenreich A, Bastian PJ, Bellmunt J et al. Guidelines on Prostate Cancer. European Association of Urology. 2012.

Abdollah F, Sun M, Suardi N et al. Prediction of functional outcomes after nerve-sparing radical prostatectomy: Results of conditional survival analyses. European Urology. 2012. Doi:10.1016/j.eururo.2012.02.057

Levinson AW, Lavery  HJ, Ward NT et al. Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy. World J Urol. 2011;29:29–34

Schmid MP, Pötter R, Bombosch V, et al. Late gastrointestinal and urogenital side-effects after radiotherapy - incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer. Radiother Oncol. 2012;104(1):114-8.

Morton GC. The emerging role of high-dose-rate brachytherapy for prostate cancer. Clinical Oncology. 2005;17:219-227.

National Institute for Health and Clinical Excellence. Interventional procedures overview - High dose rate brachytherapy for localised prostate cancer. London: NICE; 2006 [cited 2006 Aug 17].

Bhatnagar V, Stewart ST, Huynh V et al. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment. Prostate Cancer and Prostatic Diseases. 2006;1-11.

O’Connor KM & Fitzpatrick JM. Side-effects of treatments for locally advanced prostate cancer. BJU International. 2005;97:22-28.

Langley SEM & Laing RW. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer. Prostate Cancer & Prostatic Diseases. 2004;7:201-207.

Miller NL & Theodorescu D. Health-related quality of life after prostate brachytherapy. BJU International. 2004;94:487-491.

Pisansky TM, Gold DG, Furutani KM et al. High-Dose-Rate Brachytherapy in the Curative Treatment of Patients with Localised Prostate Cancer. Mayo Clin Proc. 2008;83(12):1364-72.

Morton GC, Loblaw DA, Sankreacha R et al. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life. Int J Radiat Oncol Biol Phys. 2010;77(3):811-7.

Shelley M, Wilt T, Coles B, Mason M. Cryotherapy for localised prostate cancer (Review). The Cochrane Library. 2008, Issue 4.

National Institute for Clinical Excellence. Cryotherapy for recurrent prostate cancer. Interventional procedure guidance 119. 2005

Kimura M, Mouraviev V, Tsivian M, et al. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU International.  2010;105(2):191-201.

Levy D, Avallone A,  Jones JS.  Current state of urological cryosurgery: prostate and kidney. BJU International. 2010;105(5):590-600.

Mouraviev V, Spiess PE, Jones JS. Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy. Eur Urol. 2012;61(6):1204-11.

Lukka H, Waldron T, Chin J et al. High-intensity Focused Ultrasound for Prostate Cancer: a Systematic Review. Clin Oncol. 2011;23:117-127.

Hervouet S, Savard J, Simard S E et al. Psychological functioning associated with prostate cancer: cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. J Pain Symptom Management 2005;30:474–484.

Lilleby W, Fossa S, Waehre H, Olsen DR. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys. 1998;43: 735–743.

Maliski SL, Kwan L, Orecklin JR, et al. Predictors of fatigue after treatment for prostate cancer. Urology. 2005;65:101–108.

Kyrdalen AE, Dahl AA, Hernes E, et al. Fatigue in hormone-naıve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis. 2010;13(2):144-50.

Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the androgen deprivation syndrome in men receiving androgen deprivation for prostate cancer. Archives of internal medicine. 2006;166(4): 465-71.

Stone P, Hardy J, Huddart R et al. Fatigue in patients with prostate cancer receiving hormone therapy. European journal of cancer. 2000;36(9): 1134-41.

Common thoughts and feelings

Corner J, Wagland R, Glaser A & Richards M. Qualitative analysis of patients’ feedback from a PROMs survey of cancer patients in England.  BMJ Open. 2013;3:e002316. Doi:10.1136/bmjopen-2012-002316

O’Brien R, Rose PW, Campbell C et al. Experiences of follow-up after treatment in patients with prostate cancer: a qualitative study. BJUI. 2010;106:998-1003.

Koch L, Jansen L, Brenner H & Amdt V. Fear of recurrence and disease progression in long-term (>=5 years) cancer survivors – a systematic review of quantitative studies. Psycho-Oncology. 2012. DOI: 10.1002/pon.3022

Jayadevappa R, Malkowicz SB, Chhatre S et al. The burden of depression in prostate cancer. Psychooncology. 2012;21(12):1338-45.

Ream E, Quennel A, Fincham L, et al. Supportive care needs of men living with prostate cancer in England: a survey. Br J Cancer. 2008 Jun 17;98(12):1903-9.

Wilkins D. Untold problems: A review of the essential issues in the mental health of men and boys. Men’s Health Forum. January 2010. Available at: http://www.nmhdu.org.uk/silo/files/untold-problems-a-review-of-the-essential-issues-in-the-mental-health-of-men-and-boys.pdf

What is the chance of my cancer coming back?

National Institute for Health and Clinical Excellence, Prostate Cancer: Diagnosis and Treatment (Full guidance); London: February 2008

Heidenreich A, Bolla M, Joniau S, et al. Guidelines on Prostate Cancer. European Association of Urology 2012